Articles with public access mandates - Dharmalingam SubramaniamLearn more
Not available anywhere: 4
Curcumin and turmeric attenuate arsenic-induced angiogenesis in ovo
A Varman, C Simpson-Durand, J Thorpe, C Houchen
Alternative therapies in health and medicine 16 (2), 12, 2010
Mandates: US National Institutes of Health
Halogenated Bis (methoxybenzylidene)‐4‐piperidone Curcuminoids with Improved Anticancer Activity
F Schmitt, D Subramaniam, S Anant, S Padhye, G Begemann, R Schobert, ...
ChemMedChem 13 (11), 1115-1123, 2018
Mandates: US National Institutes of Health
Cancer stem cells: novel target using dietary components for prevention and treatment
A Dhar, L Fogt, D Subramaniam, S Anant
Nutraceuticals and Cancer, 11-38, 2012
Mandates: US National Institutes of Health
Spectral and molecular modeling studies on the influence of β-cyclodextrin and its derivatives on albendazole and its anti-proliferative activity Against pancreatic cancer cells
J Shaikh, R Pradhan, PR Dandawate, D Subramaniam, S Ponnurangam, ...
Journal of Pharmaceutical Sciences and Pharmacology 3 (1), 1-14, 2017
Mandates: Council of Scientific and Industrial Research, India
Available somewhere: 59
DNA methyltransferases: a novel target for prevention and therapy
D Subramaniam, R Thombre, A Dhar, S Anant
Frontiers in oncology 4, 80, 2014
Mandates: US National Institutes of Health
Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy
PR Dandawate, D Subramaniam, RA Jensen, S Anant
Seminars in cancer biology 40, 192-208, 2016
Mandates: US National Institutes of Health
Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling
D Subramaniam, S Ponnurangam, P Ramamoorthy, D Standing, ...
PloS one 7 (2), e30590, 2012
Mandates: US National Institutes of Health
Bitter melon: a panacea for inflammation and cancer
PR Dandawate, D Subramaniam, SB Padhye, S Anant
Chinese journal of natural medicines 14 (2), 81-100, 2016
Mandates: US National Institutes of Health
Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe
SM Sureban, S Ramalingam, G Natarajan, R May, D Subramaniam, ...
Oncogene 27 (33), 4544-4556, 2008
Mandates: US National Institutes of Health
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
P Angulo, G Kaushik, D Subramaniam, P Dandawate, K Neville, ...
Journal of hematology & oncology 10, 1-13, 2017
Mandates: US National Institutes of Health
Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism
SM Sureban, R May, S Ramalingam, D Subramaniam, G Natarajan, ...
Gastroenterology 137 (2), 649-659. e2, 2009
Mandates: US National Institutes of Health
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells
S Ponnurangam, JMV Mammen, S Ramalingam, Z He, Y Zhang, S Umar, ...
Molecular cancer therapeutics 11 (4), 963-972, 2012
Mandates: US National Institutes of Health
Cancer stem cells: a novel paradigm for cancer prevention and treatment
D Subramaniam, S Ramalingam, CW Houchen, S Anant
Mini reviews in medicinal chemistry 10 (5), 359-371, 2010
Mandates: US National Institutes of Health
Helicobacter pylori's plasticity zones are novel transposable elements
D Kersulyte, WK Lee, D Subramaniam, S Anant, P Herrera, L Cabrera, ...
PloS one 4 (9), e6859, 2009
Mandates: US National Institutes of Health
Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2
D Subramaniam, G Natarajan, S Ramalingam, I Ramachandran, R May, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 294 (4 …, 2008
Mandates: US National Institutes of Health
Methanolic extracts of bitter melon inhibit colon cancer stem cells by affecting energy homeostasis and autophagy
D Kwatra, D Subramaniam, P Ramamoorthy, D Standing, E Moran, ...
Evidence‐Based Complementary and Alternative Medicine 2013 (1), 702869, 2013
Mandates: US National Institutes of Health
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis
DT Vo, D Subramaniam, M Remke, TL Burton, PJ Uren, JA Gelfond, ...
The American journal of pathology 181 (5), 1762-1772, 2012
Mandates: US National Institutes of Health
Targeting cancer stem cells for chemoprevention of pancreatic cancer
D Subramaniam, G Kaushik, P Dandawate, S Anant
Current Medicinal Chemistry 25 (22), 2585-2594, 2018
Mandates: US National Institutes of Health
RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells
D Subramaniam, S Ramalingam, DC Linehan, BK Dieckgraefe, ...
PloS one 6 (2), e16958, 2011
Mandates: US National Institutes of Health
Activation of apoptosis by 1-hydroxy-5, 7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos
D Subramaniam, P Giridharan, N Murmu, NP Shankaranarayanan, R May, ...
Cancer research 68 (20), 8573-8581, 2008
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program